DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...

Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

Learn more about whether Alvotech or Protagonist Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades ...

Early diagnosis of COPD, chronic obstructive pulmonary disease, increases the quality of life of the patient and the efficacy ...

University of Michigan labs are using advanced technology to help people like quadriplegics and amputees lead fuller lives ...

Tania Gendron, PhD, speaks to the present challenges for translating biomarker discoveries to clinical practice and offers ...

IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sc ...

Genetic testing is transforming depression treatment by tailoring antidepressants to your DNA for better results and fewer side effects.

The Association of American Medical Colleges said federal funding cuts under President Donald Trump's administration are ...

The geroscience hypothesis holds that targeting molecular pathways that drive aging can give us more healthy years. Evidence ...

Psychiatric disorders challenge us deeply. At the University of Arizona, researchers dissect their molecular roots, focusing ...